194 related articles for article (PubMed ID: 18567581)
1. Inadequate activation of the GTPase RhoA contributes to the lack of fibronectin matrix assembly in von Hippel-Lindau protein-defective renal cancer cells.
Feijóo-Cuaresma M; Méndez F; Maqueda A; Esteban MA; Naranjo-Suarez S; Castellanos MC; del Cerro MH; Vazquez SN; García-Pardo A; Landázuri MO; Calzada MJ
J Biol Chem; 2008 Sep; 283(36):24982-90. PubMed ID: 18567581
[TBL] [Abstract][Full Text] [Related]
2. Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions.
Esteban-Barragán MA; Avila P; Alvarez-Tejado M; Gutiérrez MD; García-Pardo A; Sánchez-Madrid F; Landázuri MO
Cancer Res; 2002 May; 62(10):2929-36. PubMed ID: 12019174
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.
Kurban G; Hudon V; Duplan E; Ohh M; Pause A
Cancer Res; 2006 Feb; 66(3):1313-9. PubMed ID: 16452184
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
5. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.
Ohh M; Yauch RL; Lonergan KM; Whaley JM; Stemmer-Rachamimov AO; Louis DN; Gavin BJ; Kley N; Kaelin WG; Iliopoulos O
Mol Cell; 1998 Jun; 1(7):959-68. PubMed ID: 9651579
[TBL] [Abstract][Full Text] [Related]
6. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.
Stickle NH; Chung J; Klco JM; Hill RP; Kaelin WG; Ohh M
Mol Cell Biol; 2004 Apr; 24(8):3251-61. PubMed ID: 15060148
[TBL] [Abstract][Full Text] [Related]
7. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
Lieubeau-Teillet B; Rak J; Jothy S; Iliopoulos O; Kaelin W; Kerbel RS
Cancer Res; 1998 Nov; 58(21):4957-62. PubMed ID: 9810005
[TBL] [Abstract][Full Text] [Related]
8. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
9. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
[TBL] [Abstract][Full Text] [Related]
10. Exploring the role of defective fibronectin matrix assembly in the VHL-associated CNS hemangioblastoma.
Vikkath N; Ariyannur P; Menon KN; Mr B; Pillai A
Drug Metab Pers Ther; 2018 Sep; 33(3):127-134. PubMed ID: 29813026
[No Abstract] [Full Text] [Related]
11. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
12. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms.
Calzada MJ; Esteban MA; Feijoo-Cuaresma M; Castellanos MC; Naranjo-Suárez S; Temes E; Méndez F; Yánez-Mo M; Ohh M; Landázuri MO
Cancer Res; 2006 Feb; 66(3):1553-60. PubMed ID: 16452212
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.
Pattabiraman PP; Rao PV
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C749-63. PubMed ID: 19940066
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
15. Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor.
Wacker I; Sachs M; Knaup K; Wiesener M; Weiske J; Huber O; Akçetin Z; Behrens J
Mol Cell Biol; 2009 Apr; 29(7):1707-18. PubMed ID: 19158274
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
17. von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation.
Turcotte S; Desrosiers RR; Brand G; Béliveau R
Int J Cancer; 2004 Dec; 112(5):777-86. PubMed ID: 15386385
[TBL] [Abstract][Full Text] [Related]
18. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
Bonicalzi ME; Groulx I; de Paulsen N ; Lee S
J Biol Chem; 2001 Jan; 276(2):1407-16. PubMed ID: 11024059
[TBL] [Abstract][Full Text] [Related]
19. Depleting RhoA/Stress Fiber-Organized Fibronectin Matrices on Tumor Cells Non-Autonomously Aggravates Fibroblast-Driven Tumor Cell Growth.
Huang LT; Tsai CL; Huang SH; Chang MM; Chang WT; Cheng LH; Cheng HC
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158289
[TBL] [Abstract][Full Text] [Related]
20. Opposing FlnA and FlnB interactions regulate RhoA activation in guiding dynamic actin stress fiber formation and cell spreading.
Hu J; Lu J; Goyal A; Wong T; Lian G; Zhang J; Hecht JL; Feng Y; Sheen VL
Hum Mol Genet; 2017 Apr; 26(7):1294-1304. PubMed ID: 28175289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
